Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 9/10

vs
industry
vs
history
Cash-to-Debt No Debt
ALGN's Cash-to-Debt is ranked higher than
99% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 2.43 vs. ALGN: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
ALGN' s Cash-to-Debt Range Over the Past 10 Years
Min: 5.57  Med: No Debt Max: No Debt
Current: No Debt
Equity-to-Asset 0.71
ALGN's Equity-to-Asset is ranked higher than
69% of the 269 Companies
in the Global Medical Devices industry.

( Industry Median: 0.62 vs. ALGN: 0.71 )
Ranked among companies with meaningful Equity-to-Asset only.
ALGN' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.2  Med: 0.73 Max: 0.84
Current: 0.71
-1.2
0.84
Interest Coverage 582.95
ALGN's Interest Coverage is ranked higher than
63% of the 241 Companies
in the Global Medical Devices industry.

( Industry Median: 77.33 vs. ALGN: 582.95 )
Ranked among companies with meaningful Interest Coverage only.
ALGN' s Interest Coverage Range Over the Past 10 Years
Min: 98.99  Med: No Debt Max: No Debt
Current: 582.95
Piotroski F-Score: 7
Altman Z-Score: 15.68
Beneish M-Score: -2.32
WACC vs ROIC
11.79%
57.20%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating Margin % 23.05
ALGN's Operating Margin % is ranked higher than
94% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 2.84 vs. ALGN: 23.05 )
Ranked among companies with meaningful Operating Margin % only.
ALGN' s Operating Margin % Range Over the Past 10 Years
Min: -10.89  Med: 17.06 Max: 26.54
Current: 23.05
-10.89
26.54
Net Margin % 17.57
ALGN's Net Margin % is ranked higher than
91% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 2.18 vs. ALGN: 17.57 )
Ranked among companies with meaningful Net Margin % only.
ALGN' s Net Margin % Range Over the Past 10 Years
Min: -10.01  Med: 15.47 Max: 26.31
Current: 17.57
-10.01
26.31
ROE % 20.54
ALGN's ROE % is ranked higher than
89% of the 265 Companies
in the Global Medical Devices industry.

( Industry Median: 2.23 vs. ALGN: 20.54 )
Ranked among companies with meaningful ROE % only.
ALGN' s ROE % Range Over the Past 10 Years
Min: -12.72  Med: 19.29 Max: 42.13
Current: 20.54
-12.72
42.13
ROA % 14.88
ALGN's ROA % is ranked higher than
94% of the 294 Companies
in the Global Medical Devices industry.

( Industry Median: 0.21 vs. ALGN: 14.88 )
Ranked among companies with meaningful ROA % only.
ALGN' s ROA % Range Over the Past 10 Years
Min: -9.86  Med: 14.14 Max: 31.86
Current: 14.88
-9.86
31.86
ROC (Joel Greenblatt) % 156.75
ALGN's ROC (Joel Greenblatt) % is ranked higher than
97% of the 290 Companies
in the Global Medical Devices industry.

( Industry Median: 4.32 vs. ALGN: 156.75 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
ALGN' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -114.37  Med: 151.29 Max: 369.18
Current: 156.75
-114.37
369.18
3-Year Revenue Growth Rate 18.40
ALGN's 3-Year Revenue Growth Rate is ranked higher than
86% of the 229 Companies
in the Global Medical Devices industry.

( Industry Median: 4.70 vs. ALGN: 18.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
ALGN' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 7.6  Med: 15.4 Max: 146.7
Current: 18.4
7.6
146.7
3-Year EBITDA Growth Rate 35.60
ALGN's 3-Year EBITDA Growth Rate is ranked higher than
86% of the 200 Companies
in the Global Medical Devices industry.

( Industry Median: 5.60 vs. ALGN: 35.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
ALGN' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -35.3  Med: 25.45 Max: 45.2
Current: 35.6
-35.3
45.2
3-Year EPS without NRI Growth Rate 44.00
ALGN's 3-Year EPS without NRI Growth Rate is ranked higher than
85% of the 197 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. ALGN: 44.00 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
ALGN' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -76.1  Med: 20.1 Max: 289.3
Current: 44
-76.1
289.3
GuruFocus has detected 2 Warning Signs with Align Technology Inc $ALGN.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ALGN's 10-Y Financials

Financials (Next Earnings Date: 2017-05-01 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

ALGN Guru Trades in Q1 2016

John Hussman 43,000 sh (New)
RS Investment Management 569,189 sh (+83.43%)
Jim Simons 700,807 sh (+14.09%)
Columbia Wanger 3,075,617 sh (+4.53%)
Ken Fisher 113,581 sh (+1.61%)
Ron Baron 27,500 sh (unchged)
Paul Tudor Jones Sold Out
Pioneer Investments 336,601 sh (-16.13%)
Mario Gabelli 5,000 sh (-16.67%)
Mariko Gordon 58,382 sh (-20.26%)
Ruane Cunniff 54,433 sh (-20.64%)
Steven Cohen 17,800 sh (-85.53%)
» More
Q2 2016

ALGN Guru Trades in Q2 2016

Joel Greenblatt 15,104 sh (New)
Paul Tudor Jones 5,745 sh (New)
Steven Cohen 50,600 sh (+184.27%)
Jim Simons 839,200 sh (+19.75%)
RS Investment Management 601,734 sh (+5.72%)
Ken Fisher 116,266 sh (+2.36%)
Mario Gabelli 5,000 sh (unchged)
John Hussman 43,000 sh (unchged)
Ron Baron 26,640 sh (-3.13%)
Pioneer Investments 318,435 sh (-5.40%)
Ruane Cunniff 48,123 sh (-11.59%)
Columbia Wanger 2,393,012 sh (-22.19%)
Mariko Gordon 42,420 sh (-27.34%)
» More
Q3 2016

ALGN Guru Trades in Q3 2016

Steve Mandel 2,436,920 sh (New)
George Soros 2,515 sh (New)
Jim Simons 944,200 sh (+12.51%)
Ron Baron 26,640 sh (unchged)
Ruane Cunniff 48,123 sh (unchged)
John Hussman Sold Out
Paul Tudor Jones 5,700 sh (-0.78%)
Ken Fisher 109,455 sh (-5.86%)
Pioneer Investments 278,266 sh (-12.61%)
Mario Gabelli 4,000 sh (-20.00%)
Mariko Gordon 30,286 sh (-28.60%)
Columbia Wanger 1,614,224 sh (-32.54%)
Steven Cohen 25,300 sh (-50.00%)
Joel Greenblatt 2,504 sh (-83.42%)
» More
Q4 2016

ALGN Guru Trades in Q4 2016

John Hussman 50,000 sh (New)
Jim Simons 1,316,500 sh (+39.43%)
Mariko Gordon 32,066 sh (+5.88%)
Pioneer Investments 285,369 sh (+2.55%)
Steve Mandel 2,476,534 sh (+1.63%)
Ron Baron 26,640 sh (unchged)
Joel Greenblatt Sold Out
George Soros Sold Out
Paul Tudor Jones Sold Out
Ruane Cunniff 48,118 sh (-0.01%)
Ken Fisher 102,242 sh (-6.59%)
Columbia Wanger 1,400,451 sh (-13.24%)
Mario Gabelli 2,500 sh (-37.50%)
Steven Cohen 8,000 sh (-68.38%)
» More
» Details

Insider Trades

Latest Guru Trades with ALGN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 339113    SIC: 3842
Compare:OTCPK:SONVY, NYSE:TFX, NYSE:VAR, OTCPK:SDMHF, OTCPK:CHEOY, OTCPK:CNVVY, OTCPK:WILLF, NAS:ABMD, NAS:MASI, OTCPK:SNNUF, OTCPK:FSPKF, NAS:NUVA, OTCPK:EKTAY, OTCPK:GGNDF, NAS:WMGI, NAS:IART, NYSE:GMED, NYSE:NVRO, NYSE:PEN, NAS:LIVN » details
Traded in other countries:AFW.Germany,
Align Technology Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM digital services used in dentistry, orthodontics, and dental records storage.

Align Technology Inc was incorporated in Delaware in April 1997. The Company designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The Company has two operating segments: Clear Aligner and Scanners and Services. The Clear Aligner segment consists of its Invisalign System which includes Invisalign Full, Express/Lite, Teen, Assist, Vivera Retainers, along with its training and ancillary products for treating malocclusion. The Scanners and Services segment consists of intra-oral scanning systems, and additional services available with the intra-oral scanners, that provide digital alternatives to the traditional cast models. This segment includes its iTero scanner and OrthoCAD services. The Company is subject to various laws inside and outside the U.S. concerning its relationships with healthcare professionals and government officials, price reporting and regulation, the promotion, sales and marketing of its products and services, the importation and exportation of its products, the operation of its facilities and distribution of its products. It is also subject to varying degrees of government regulation in the various countries in which the Company do business.

Ratios

vs
industry
vs
history
PE Ratio 48.79
ALGN's PE Ratio is ranked lower than
75% of the 198 Companies
in the Global Medical Devices industry.

( Industry Median: 26.64 vs. ALGN: 48.79 )
Ranked among companies with meaningful PE Ratio only.
ALGN' s PE Ratio Range Over the Past 10 Years
Min: 5.57  Med: 32.45 Max: 222.88
Current: 48.79
5.57
222.88
Forward PE Ratio 38.31
ALGN's Forward PE Ratio is ranked lower than
79% of the 57 Companies
in the Global Medical Devices industry.

( Industry Median: 23.98 vs. ALGN: 38.31 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 48.79
ALGN's PE Ratio without NRI is ranked lower than
73% of the 181 Companies
in the Global Medical Devices industry.

( Industry Median: 28.00 vs. ALGN: 48.79 )
Ranked among companies with meaningful PE Ratio without NRI only.
ALGN' s PE Ratio without NRI Range Over the Past 10 Years
Min: 5.57  Med: 32.45 Max: 222.88
Current: 48.79
5.57
222.88
Price-to-Owner-Earnings 64.35
ALGN's Price-to-Owner-Earnings is ranked lower than
80% of the 106 Companies
in the Global Medical Devices industry.

( Industry Median: 30.84 vs. ALGN: 64.35 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
ALGN' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.35  Med: 31.33 Max: 895
Current: 64.35
5.35
895
PB Ratio 9.11
ALGN's PB Ratio is ranked lower than
87% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 3.37 vs. ALGN: 9.11 )
Ranked among companies with meaningful PB Ratio only.
ALGN' s PB Ratio Range Over the Past 10 Years
Min: 1.86  Med: 5.24 Max: 15.87
Current: 9.11
1.86
15.87
PS Ratio 8.58
ALGN's PS Ratio is ranked lower than
81% of the 329 Companies
in the Global Medical Devices industry.

( Industry Median: 3.34 vs. ALGN: 8.58 )
Ranked among companies with meaningful PS Ratio only.
ALGN' s PS Ratio Range Over the Past 10 Years
Min: 1.3  Med: 4.57 Max: 8.62
Current: 8.58
1.3
8.62
Price-to-Free-Cash-Flow 52.50
ALGN's Price-to-Free-Cash-Flow is ranked lower than
77% of the 124 Companies
in the Global Medical Devices industry.

( Industry Median: 28.14 vs. ALGN: 52.50 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
ALGN' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 10.89  Med: 23.29 Max: 52.72
Current: 52.5
10.89
52.72
Price-to-Operating-Cash-Flow 37.56
ALGN's Price-to-Operating-Cash-Flow is ranked lower than
79% of the 155 Companies
in the Global Medical Devices industry.

( Industry Median: 20.26 vs. ALGN: 37.56 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
ALGN' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 8.19  Med: 19.91 Max: 361.07
Current: 37.56
8.19
361.07
EV-to-EBIT 34.26
ALGN's EV-to-EBIT is ranked lower than
71% of the 221 Companies
in the Global Medical Devices industry.

( Industry Median: 22.27 vs. ALGN: 34.26 )
Ranked among companies with meaningful EV-to-EBIT only.
ALGN' s EV-to-EBIT Range Over the Past 10 Years
Min: -378.4  Med: 21.9 Max: 157.9
Current: 34.26
-378.4
157.9
EV-to-EBITDA 31.28
ALGN's EV-to-EBITDA is ranked lower than
78% of the 238 Companies
in the Global Medical Devices industry.

( Industry Median: 16.71 vs. ALGN: 31.28 )
Ranked among companies with meaningful EV-to-EBITDA only.
ALGN' s EV-to-EBITDA Range Over the Past 10 Years
Min: -248.4  Med: 19.6 Max: 578.7
Current: 31.28
-248.4
578.7
PEG Ratio 2.08
ALGN's PEG Ratio is ranked higher than
59% of the 80 Companies
in the Global Medical Devices industry.

( Industry Median: 2.49 vs. ALGN: 2.08 )
Ranked among companies with meaningful PEG Ratio only.
ALGN' s PEG Ratio Range Over the Past 10 Years
Min: 1.33  Med: 1.7 Max: 2.72
Current: 2.08
1.33
2.72
Shiller PE Ratio 102.14
ALGN's Shiller PE Ratio is ranked lower than
84% of the 50 Companies
in the Global Medical Devices industry.

( Industry Median: 53.11 vs. ALGN: 102.14 )
Ranked among companies with meaningful Shiller PE Ratio only.
ALGN' s Shiller PE Ratio Range Over the Past 10 Years
Min: 73.35  Med: 95.36 Max: 680.5
Current: 102.14
73.35
680.5
Current Ratio 2.69
ALGN's Current Ratio is ranked higher than
58% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 2.28 vs. ALGN: 2.69 )
Ranked among companies with meaningful Current Ratio only.
ALGN' s Current Ratio Range Over the Past 10 Years
Min: 1.59  Med: 2.82 Max: 4.57
Current: 2.69
1.59
4.57
Quick Ratio 2.61
ALGN's Quick Ratio is ranked higher than
68% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 1.65 vs. ALGN: 2.61 )
Ranked among companies with meaningful Quick Ratio only.
ALGN' s Quick Ratio Range Over the Past 10 Years
Min: 1.55  Med: 2.76 Max: 4.49
Current: 2.61
1.55
4.49
Days Inventory 32.71
ALGN's Days Inventory is ranked higher than
90% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: 124.59 vs. ALGN: 32.71 )
Ranked among companies with meaningful Days Inventory only.
ALGN' s Days Inventory Range Over the Past 10 Years
Min: 9.28  Med: 24.09 Max: 32.75
Current: 32.71
9.28
32.75
Days Sales Outstanding 83.63
ALGN's Days Sales Outstanding is ranked lower than
69% of the 243 Companies
in the Global Medical Devices industry.

( Industry Median: 67.79 vs. ALGN: 83.63 )
Ranked among companies with meaningful Days Sales Outstanding only.
ALGN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 57.57  Med: 63.3 Max: 83.63
Current: 83.63
57.57
83.63
Days Payable 39.45
ALGN's Days Payable is ranked lower than
70% of the 229 Companies
in the Global Medical Devices industry.

( Industry Median: 57.49 vs. ALGN: 39.45 )
Ranked among companies with meaningful Days Payable only.
ALGN' s Days Payable Range Over the Past 10 Years
Min: 25.83  Med: 46.94 Max: 68.75
Current: 39.45
25.83
68.75

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 0.40
ALGN's 3-Year Average Share Buyback Ratio is ranked higher than
87% of the 212 Companies
in the Global Medical Devices industry.

( Industry Median: -3.60 vs. ALGN: 0.40 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ALGN' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -139.2  Med: -3.4 Max: 0.5
Current: 0.4
-139.2
0.5

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 37.95
ALGN's Price-to-Net-Cash is ranked lower than
82% of the 119 Companies
in the Global Medical Devices industry.

( Industry Median: 15.38 vs. ALGN: 37.95 )
Ranked among companies with meaningful Price-to-Net-Cash only.
ALGN' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 4.84  Med: 17.2 Max: 117.93
Current: 37.95
4.84
117.93
Price-to-Net-Current-Asset-Value 16.46
ALGN's Price-to-Net-Current-Asset-Value is ranked lower than
81% of the 240 Companies
in the Global Medical Devices industry.

( Industry Median: 6.87 vs. ALGN: 16.46 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
ALGN' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 3.44  Med: 8.8 Max: 25.8
Current: 16.46
3.44
25.8
Price-to-Tangible-Book 9.95
ALGN's Price-to-Tangible-Book is ranked lower than
80% of the 285 Companies
in the Global Medical Devices industry.

( Industry Median: 4.36 vs. ALGN: 9.95 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
ALGN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.16  Med: 6.41 Max: 15.4
Current: 9.95
2.16
15.4
Price-to-Intrinsic-Value-Projected-FCF 3.12
ALGN's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
67% of the 147 Companies
in the Global Medical Devices industry.

( Industry Median: 2.09 vs. ALGN: 3.12 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
ALGN' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.73  Med: 2.11 Max: 14.5
Current: 3.12
1.73
14.5
Price-to-Median-PS-Value 1.89
ALGN's Price-to-Median-PS-Value is ranked lower than
85% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 1.10 vs. ALGN: 1.89 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
ALGN' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.4  Med: 0.9 Max: 1.89
Current: 1.89
0.4
1.89
Price-to-Peter-Lynch-Fair-Value 1.95
ALGN's Price-to-Peter-Lynch-Fair-Value is ranked lower than
56% of the 59 Companies
in the Global Medical Devices industry.

( Industry Median: 1.67 vs. ALGN: 1.95 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
ALGN' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.57  Med: 1.84 Max: 3.01
Current: 1.95
0.57
3.01
Price-to-Graham-Number 4.65
ALGN's Price-to-Graham-Number is ranked lower than
75% of the 146 Companies
in the Global Medical Devices industry.

( Industry Median: 2.10 vs. ALGN: 4.65 )
Ranked among companies with meaningful Price-to-Graham-Number only.
ALGN' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.96  Med: 3.36 Max: 7.89
Current: 4.65
0.96
7.89
Earnings Yield (Greenblatt) % 2.93
ALGN's Earnings Yield (Greenblatt) % is ranked higher than
63% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 0.86 vs. ALGN: 2.93 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
ALGN' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.6  Med: 4.2 Max: 9.7
Current: 2.93
0.6
9.7
Forward Rate of Return (Yacktman) % 30.99
ALGN's Forward Rate of Return (Yacktman) % is ranked higher than
92% of the 119 Companies
in the Global Medical Devices industry.

( Industry Median: 9.85 vs. ALGN: 30.99 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
ALGN' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -5.8  Med: 2.7 Max: 31.4
Current: 30.99
-5.8
31.4

More Statistics

Revenue (TTM) (Mil) $1,080
EPS (TTM) $ 2.34
Beta1.25
Short Percentage of Float6.21%
52-Week Range $69.71 - 114.99
Shares Outstanding (Mil)80.28

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 1,301 1,522
EPS ($) 2.98 3.53
EPS without NRI ($) 2.98 3.53
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)
» More Articles for ALGN

Headlines

Articles On GuruFocus.com
6 Stocks That Are Beating the Market Oct 11 2016 
Most-Bought Small Cap Stocks During 4th Quarter Mar 28 2016 
Align Technology – Can It Align Your Portfolio to Smile? Mar 18 2016 
Ruane Cunniff's Top New Buys of 3rd Quarter Dec 15 2015 
Valeant Top Shareholder Sequoia Fund's Largest New Buys Nov 19 2015 
Valeant Pharmaceuticals Part X: a follow up on the sale of facial injectables Aug 11 2014 
WEEKLY CFO SELLS HIGHLIGHT: CY, UTEK, STJ, ALGN, TXN, JAH, YUM May 01 2011 
Align Technologies Takes One in the Teeth Apr 06 2010 
Weekly CEO Sells Highlight: Rockwell Automation Inc. Common, Penske Automotive Group Inc., Align Tec Feb 07 2010 
Align Technology Inc. (ALGN) President and CEO Thomas M Prescott sells 328,596 Shares Feb 03 2010 

More From Other Websites
8:32 am Align Tech announces the PTAB issued its Final Written Decision finding that claims 1, 2, 9,... Mar 28 2017
Align Technology Prevails in Additional U.S. Patent Office Proceedings Initiated by ClearCorrect Mar 28 2017
Align Partners Zfx GmbH to Expand iTero Scanner Business Mar 27 2017
Can this non-Trump play keep climbing? Mar 24 2017
Align Technology Announces Agreement With Zfx GmbH to Expand Restorative and Laboratory Network for... Mar 24 2017
Align's iTero Hits 1 Billion Mark, Boosts Scanner Business Mar 22 2017
Align Technology Reaches Major Milestone for the iTero Element(R) Scanner With Over One Million... Mar 21 2017
Align Technology Announces Seamless New Connection Between iTero Intraoral Scanners and exocad... Mar 21 2017
Align Technology Announces Treatment Planning Collaboration With Digital Smile Design Mar 20 2017
Align Technology Announces Digital Implant Workflow for Its iTero(R) Scanners With Nobel Biocare(R)... Mar 20 2017
Align Technology Hits a 52-Week High on Solid Prospects Mar 16 2017
ALIGN TECHNOLOGY INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Mar 14 2017
Susan E. Siegel Joins Align Technology Board of Directors Mar 14 2017
Align Technology to Speak at Upcoming Financial Conference Mar 08 2017
Align Technology Announces New Teen Solution With Introduction of Invisalign Teen With Mandibular... Mar 06 2017
Align Technology Announces New Teen Solution With Introduction of Invisalign Teen With Mandibular... Mar 06 2017
ALIGN TECHNOLOGY INC Financials Mar 04 2017
ALIGN TECHNOLOGY INC Files SEC form 10-K, Annual Report Feb 28 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)